Skip to main content
SpringerLink
Log in

Loop diuretics in heart failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Congestion is a major component of the clinical syndrome of heart failure, and diuretic therapy remains the cornerstone of congestion management. Despite being widely used, there is very limited evidence from prospective randomized studies to guide the prescription and titration of diuretics. A thorough understanding of the pharmacology of loop diuretics is crucial to the optimal use of these agents. Although multiple observational studies have suggested that high doses of diuretics may be harmful, all such analyses are confounded by the association of higher diuretic doses with greater severity of illness and comorbidity. Recent data from randomized trials suggest that higher doses of diuretics may be more effective at relieving congestion and that associated changes in renal function are typically transient. Data from other ongoing trials will continue to inform our understanding of the optimal role for loop diuretics in the treatment of heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JEA, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Nieminen M, Pang PS, Seferovic P, Stevenson LW, van Veldhuisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJV, Filippatos G (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12(5):423–433. doi:10.1093/eurjhf/hfq045

    Article  PubMed  Google Scholar 

  2. Shah MR, Stevenson LW (2004) Searching for evidence: refractory questions in advanced heart failure. J Card Fail 10(3):210–218

    Article  PubMed  Google Scholar 

  3. Adams KF, Lindenfeld J, Arnold JM, Baker D, Barnhard DH, Baughman KL, Boehmer JP, Deedwania P, Dunbar SB, Elkayam U, Gheorghiade M, Howlett J, Konstam MA, Kronenberg MW, Massie BM, Mehra MR, Miller AB, Moser DK, Patterson JK, Rodeheffer RJ, Sackner-Bernstein JD, Silver MA, Starling MR, Stevenson LW, Wagoner LE (2006) HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 12:1–119

    Article  Google Scholar 

  4. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14):1977–2016. doi:10.1161/CIRCULATIONAHA.109.192064

    Article  PubMed  Google Scholar 

  5. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29(19):2388–2442. doi:10.1093/eurheartj/ehn309

    Google Scholar 

  6. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudintoretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left-ventricular dysfunction with and without congestive-heart-failure—a substudy of the studies of left-ventricular dysfunction (SOLVD). Circulation 82(5):1724–1729

    Article  PubMed  CAS  Google Scholar 

  7. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN (1985) Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart-failure–activation of the neurohumoral axis. Ann Intern Med 103(1):1–6

    PubMed  CAS  Google Scholar 

  8. Ellison DH (2001) Diuretic therapy and resistance in congestive heart failure. Cardiology 96(3–4):132–143

    Article  PubMed  CAS  Google Scholar 

  9. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC (1995) Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure[ast]. Clin Pharmacol Ther 57(6):601–609

    Article  PubMed  CAS  Google Scholar 

  10. Murray MD, Deer MM, Ferguson JA, Dexter PR, Bennett SJ, Perkins SM, Smith FE, Lane KA, Adams LD, Tierney WM, Brater DC (2001) Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 111(7):513–520. doi:10.1016/s0002-9343(01)00903-2

    Article  PubMed  CAS  Google Scholar 

  11. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the acute decompensated heart failure national registry (ADHERE). Am Heart J 149(2):209–216

    Article  PubMed  Google Scholar 

  12. Loon NR, Wilcox CS, Unwin RJ (1989) Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 36(4):682–689

    Article  PubMed  CAS  Google Scholar 

  13. Kaissling B, Bachmann S, Kriz W (1985) Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol 248(3 Pt 2):F374–F381

    Google Scholar 

  14. Salvador DRK, Punzalan FE, Ramos GC (2005) Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev, Issue 3, Art. No.: CD003178. doi:10.1002/14651858.CD003178.pub3

  15. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797–805. doi:10.1056/NEJMoa1005419

    Article  PubMed  CAS  Google Scholar 

  16. Jentzer JC, DeWald TA, Hernandez AF (2010) Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 56(19):1527–1534. doi:10.1016/j.jacc.2010.06.034

    Article  PubMed  CAS  Google Scholar 

  17. Iraqi W, Rossignol P, Angioi M, Fay R, Nuee J, Ketelslegers JM, Vincent J, Pitt B, Zannad F (2009) Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS) study. Circulation 119(18):2471–2479. doi:10.1161/circulationaha.108.809194

    Article  PubMed  CAS  Google Scholar 

  18. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 341(10):709–717

    Google Scholar 

  19. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364(1):11–21. doi:10.1056/NEJMoa1009492

    Article  PubMed  CAS  Google Scholar 

  20. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309–1321. doi:10.1056/NEJMoa030207

    Article  PubMed  CAS  Google Scholar 

  21. Bansal S, Lindenfeld J, Schrier RW (2009) Sodium retention in heart failure and cirrhosis. Circ Heart Fail 2(4):370–376. doi:10.1161/circheartfailure.108.821199

    Article  PubMed  CAS  Google Scholar 

  22. Felker GM, O’Connor CM, Braunwald E, for the Heart Failure Clinical Research Network Investigators (2009) Loop diuretics in acute decompensated heart failure: necessary? evil? a necessary evil? Circ Heart Fail 2(1):56–62. doi:10.1161/circheartfailure.108.821785

    Google Scholar 

  23. McCurley JM, Hanlon SU, Wei Sk, Wedam EF, Michalski M, Haigney MC (2004) Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 44(6):1301–1307

    Article  PubMed  CAS  Google Scholar 

  24. Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A (2002) Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 82(2):149–158. doi:10.1016/s0167-5273(01)00600-3

    Article  PubMed  CAS  Google Scholar 

  25. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100:1311–1315

    PubMed  CAS  Google Scholar 

  26. Ahmed A, Husain A, Love TE, Gambassi G, Dell’Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC (2006) Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27(12):1431–1439

    Article  PubMed  Google Scholar 

  27. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O’Connor CM, Rich MW, Stevenson LW, Wang Y (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147(2):331–338

    Article  PubMed  Google Scholar 

  28. Hasselblad V, Stough WG, Shah MR, Lokhnygina Y, O’Connor CM, Califf RM, Adams KF Jr (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE Trial. Eur J Heart Fail 9(10):1064–1069

    Article  PubMed  CAS  Google Scholar 

  29. Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TDJ, Cleland JGF, van Veldhuisen DJ, Hillege HL (2007) Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13(8):599–608

    Article  PubMed  Google Scholar 

  30. Aronson D, Burger AJ (2010) The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J Card Fail 16(7):541–547. doi:10.1016/j.cardfail.2010.02.001

    Article  PubMed  Google Scholar 

  31. Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265–272. doi:10.1161/circulationaha.109.933275

    Article  PubMed  Google Scholar 

  32. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53(7):589–596. doi:10.1016/j.jacc.2008.05.068

    Article  PubMed  Google Scholar 

  33. Stevenson LW, Zile M, Bennett TD, Kueffer FJ, Jessup ML, Adamson P, Abraham WT, Manda V, Bourge RC (2010) Chronic ambulatory intracardiac pressures and future heart failure events. Circ Heart Fail 3(5):580–587. doi:10.1161/circheartfailure.109.923300

    Article  PubMed  Google Scholar 

  34. Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C, h Tolvaptan I (2007) Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials. JAMA 297(12):1332–1343

    Article  PubMed  CAS  Google Scholar 

  35. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C, h Tolvaptan I (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297(12):1319–1331

    Article  PubMed  CAS  Google Scholar 

  36. Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JGF, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC (2010) Rolofylline, an adenosine A1–receptor antagonist, in acute heart failure. N Engl J Med 363(15):1419–1428. doi:10.1056/NEJMoa0912613

    Article  PubMed  Google Scholar 

  37. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49(6):675–683

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

No conflict of interest with regard to the contents of this manuscript.

Author information

Authors and Affiliations

  1. Divisions of Cardiology and Clinical Pharmacology, Duke Clinical Research Institute, Duke University School of Medicine, 2400 Pratt St, Room 0311 Terrace Level, Durham, NC, 27705, USA

    G. Michael Felker

Authors
  1. G. Michael Felker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Michael Felker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Felker, G.M. Loop diuretics in heart failure. Heart Fail Rev 17, 305–311 (2012). https://doi.org/10.1007/s10741-011-9245-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-011-9245-3

Keywords

Search

Navigation